87 related articles for article (PubMed ID: 6376235)
1. The effect of a new specific alpha-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.
Eichler HG; Korn A; Gasic S; Pirson W; Businger J
Diabetologia; 1984 Apr; 26(4):278-81. PubMed ID: 6376235
[TBL] [Abstract][Full Text] [Related]
2. Effect of trestatin, a new inhibitor of pancreatic alpha-amylase, on starch metabolism in man.
Tappy L; Buckert A; Griessen M; Golay A; Jéquier E; Felber J
Int J Obes; 1986; 10(3):185-92. PubMed ID: 3531052
[TBL] [Abstract][Full Text] [Related]
3. Effect of trestatin, an amylase inhibitor, incorporated into bread, on glycemic responses in normal and diabetic patients.
Golay A; Schneider H; Temler E; Felber JP
Am J Clin Nutr; 1991 Jan; 53(1):61-5. PubMed ID: 1701612
[TBL] [Abstract][Full Text] [Related]
4. Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetic patients.
Bornet F; Haardt MJ; Costagliola D; Blayo A; Slama G
Diabetologia; 1985 Apr; 28(4):213-7. PubMed ID: 3894134
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics.
Bevan JS; Ara J; Page MD; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1991 Jul; 35(1):85-91. PubMed ID: 1889143
[TBL] [Abstract][Full Text] [Related]
6. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro.
Gin H; Rigalleau V; Caubet O; Masquelier J; Aubertin J
Metabolism; 1999 Sep; 48(9):1179-83. PubMed ID: 10484061
[TBL] [Abstract][Full Text] [Related]
7. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
8. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
Hayakawa T; Noda A; Kondo T; Okumura N
Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
[No Abstract] [Full Text] [Related]
9. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
[TBL] [Abstract][Full Text] [Related]
10. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
11. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
Chiasson JL; Josse RG; Leiter LA; Mihic M; Nathan DM; Palmason C; Cohen RM; Wolever TM
Diabetes Care; 1996 Nov; 19(11):1190-3. PubMed ID: 8908378
[TBL] [Abstract][Full Text] [Related]
12. Determination and kinetic analysis of non-insulin mediated glucose uptake in type 1 (insulin-dependent) diabetes mellitus.
Shumak SL; Gulan M; Zinman B; Gottesman IS
Diabetologia; 1989 Jan; 32(1):28-33. PubMed ID: 2651186
[TBL] [Abstract][Full Text] [Related]
13. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
[TBL] [Abstract][Full Text] [Related]
14. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
Gérard J; Luyckx AS; Lefebvre PJ
Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
[TBL] [Abstract][Full Text] [Related]
17. New alpha-amylase inhibitor, trestatins. III. Structure determination of new trestatin components Ro 09-0766, Ro 09-0767 and Ro 09-0768.
Yokose K; Ogawa M; Ogawa K
J Antibiot (Tokyo); 1984 Feb; 37(2):182-6. PubMed ID: 6608512
[No Abstract] [Full Text] [Related]
18. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
Matthews DR; Boland O
Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
[TBL] [Abstract][Full Text] [Related]
19. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients.
Larsen JJ; Dela F; Kjaer M; Galbo H
Diabetologia; 1997 Apr; 40(4):447-53. PubMed ID: 9112022
[TBL] [Abstract][Full Text] [Related]
20. Insulin infusion (GIK) in the treatment of type 2 (non-insulin dependent) diabetes during the perioperative period.
Thomas DJ; Platt HS; Alberti KG
Br J Surg; 1986 Nov; 73(11):898-901. PubMed ID: 3790919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
